Next Article in Journal
Integrative Analysis of the Transcriptome and Metabolome Reveals the Developmental Mechanisms and Metabolite Biosynthesis of the Tuberous Roots of Tetrastigma hemsleyanum
Next Article in Special Issue
CBD in the Treatment of Epilepsy
Previous Article in Journal
Gastrodin and Gastrodigenin Improve Energy Metabolism Disorders and Mitochondrial Dysfunction to Antagonize Vascular Dementia
Previous Article in Special Issue
Anti-Amyloidogenic Effects of Metasequoia glyptostroboides Fruits and Its Active Constituents
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity

1
Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea
2
Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea
3
Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2023, 28(6), 2602; https://doi.org/10.3390/molecules28062602
Submission received: 21 February 2023 / Revised: 9 March 2023 / Accepted: 11 March 2023 / Published: 13 March 2023
(This article belongs to the Collection Bioactive Natural Molecules from Functional Foods)

Abstract

:
A new bicyclic nonene, tsaokoic acid (1), was isolated from the fruits of Amomum tsao-ko, together with three known compounds (24). The structure of 1 was elucidated by analyzing spectroscopic data including 1D and 2D NMR spectra and compounds 24 were identified as tsaokoin, vanillin, and tsaokoarylone, respectively, by comparing their NMR spectra with previously reported data. Compounds 14 showed possible inhibitory activity against acetylcholinesterase (AChE) in silico molecular docking simulations. They were submitted to in vitro assay system and exhibited moderate inhibitory activity with IC50 values of 32.78, 41.70, 39.25, and 31.13 μM, respectively.

1. Introduction

Amomum tsao-ko Crevost et Lemair (Zingiberaceae) is a medicinal food known as “Cho-Gwa” in Korea and “Caoguo” or “Tsao-ko” in China [1]. The genus Amomum is distributed in tropical and subtropical regions of Asia and Oceania, and A. tsao-ko grows mainly in Southwestern China and Northern Vietnam [2,3]. The fruit of A. tsao-ko has been used as a spice and a traditional medicine in Asia to treat stomach disorders, dyspepsia, nausea, vomiting, diarrhea, malaria, throat infections, and abdominal pain [4,5,6]. It exhibits pharmacological activities such as anti-inflammatory, anti-tumor, anti-oxidant, anti-biotic, anti-diabetic, and neuroprotective effects [3,5,7]. Previous phytochemical studies on A. tsao-ko fruit isolated various natural compounds including flavonoids, terpenoids, and diarylheptanoids [2].
Alzheimer’s disease (AD) is a neurodegenerative disorder accompanied by clinical symptoms such as cognitive and language impairment, mental and behavioral difficulties, and problems with daily living activities. Although AD pathogenesis has not been clearly elucidated, one cause may be early loss of basal forebrain cholinergic neurons [8]. This explains the essential role of acetylcholine (ACh) in cognitive decline (including memory, attention, sensory, and learning) in AD [9]. Since cholinergic neurotransmission plays an important role in cognitive function, improving the acetylcholinesterase (AChE) brain level is crucial to treat AD. AChE is a cholinergic enzyme found primarily at neuromuscular junctions and chemical synapses of the cholinergic type responsible for terminating a synaptic transmission. Therefore, AChE inhibitors enhance cholinergic neurotransmission by increasing Ach levels [8,9].
In this study, a new compound, tsaokoic acid (1), was isolated with three known compounds, tsaokoin (2), vanillin (3), and tsaokoarylone (4), from the A. tsao-ko fruits (Figure 1). 14 were tested for their AChE-inhibitory activity using an in silico molecular docking and an in vitro enzyme assay. This study describes their isolation, structure identification, and AChE-inhibitory activity.

2. Results and Discussion

2.1. Structure Elucidation

Compound 1 was obtained as white needles, and it exhibited a molecular ion peak at m/z 181.0868 [M − H] (calcd for 181.0870) in the HRESIMS, consistent with the molecular formula C10H14O3. The UV spectrum of 1 showed an absorption maximum at 240 nm. In the IR spectrum of 1, a hydroxyl group and carboxylic acid functionality were observed at 2954 and 1685 cm−1, respectively. In the 1H and 13C NMR spectra of 1, as shown in Table 1, four methylene functionalities appeared at δH 2.32 (1H, ddt, J = 17.8, 6.0, 1.5 Hz), 2.22 (1H, ddt, J = 18.0, 9.4, 2.9)/δC 30.8 (C-4), 1.72 (1H, dddd, J = 16.4, 8.4, 5.2, 4.1), 1.55 (1H, m)/26.0 (C-7), 1.55 (2H, m)/25.4 (C-8), and 2.03 (1H, dq, J = 5.8, 2.4), 1.45 (1H, m)/34.2 (C-9). Four methines were also observed at δH 6.78 (1H, dq, J = 6.0, 1.5 Hz)/δC 136.5 (C-3), 3.94 (1H, dt, J = 9.6, 4.8)/68.9 (C-5), 3.01 (1H, ddt, J = 9.8, 3.3, 1.6)/40.9 (C-1), and 2.41 (1H, dddd, J = 12.6, 8.0, 4.0, 1.4)/44.6 (C-6) together with a quaternary carbon peak at δC 135.9 (C-2), indicating the presence of a bicyclic nonene [1]. In the HMBC spectrum of 1, the bicyclic nonene group was confirmed by the correlations of H-1/C-2, C-9, H-3/C-1, C-2, C-4, C-5, H-4/C-2, C-3, C-5, C-6, H-6/C-1, C-2, C-4, C-5, C-7, H-7/C-1, C-5, C-6, C-8, C-9, H-8/C-1, C-6, C-9, and H-9/C-1, C-2, C-6, C-7, C-8. In addition, the 13C NMR resonance at δC 170.7 (C-10) displayed a carboxylic acid in 1. A hydroxyl group was expected from molecular ion peak of HRESIMS. The carboxylic acid was positioned at C-2 due to the HMBC correlation between the proton H-3 at δH 6.78 and the carboxylic carbon at δC 170.7 (C-10) (Figure 2) which are three bonds away from each other. The hydroxyl group was assigned at C-5 (δC 68.9) as a secondary hydroxyl since the H-5 at δH 3.94 showed two-bond correlations with C-4 and C-6 and three-bond connectivities with C-1, C-3, and C-7 in the HMBC NMR spectrum of 1. As a result, the structure of 1 was similar to tsaokoin (2) [1], except for the carboxylic acid in 1 instead of an aldehyde group in tsaokoin (2) at C-10.
The relative configuration of 1 was determined by analyzing its NOESY spectrum (Figure 2). The NOE correlations of H-1/H-5, H-1/H-6, and H-5/H-6 indicated that the three protons of H-1, H-5, H-6 are cofacial, while a hydroxyl group at C-5 is on the opposite side. Therefore, the structure of 1 was determined as a new compound, rel-(1R,5R,6S)-5-hydroxybicyclo[4.3.0]non-2-ene-2-carboxylic acid (Figure 1), namely, “tsaokoic acid”.
Compound 2 was isolated as a colorless oil and its molecular formula determined as C10H14O2 based on the HRESIMS ([M + H]+, m/z 167.1072, calcd for 167.1067). The 1H and 13C chemical shifts (Table 1) of 2 also exhibited peak values for bicyclic nonene fragments that were identical to those of tsaokoin [1,10]. 13C NMR resonances at C-2 (δC 144.9) and C-3(δC 146.5) showed larger chemical shifts compared to those of 1. Unlike 1, δH 9.42 (s)/δC 193.8 (C-10) showed the presence of carbaldehyde group instead of carboxylic group at C-2 position, which was supported by the HMBC correlations between H-10/C-1, C-2, and C-3 and NOESY correlations of H-3/H-10. The relative configuration of 2 was confirmed as 1R,5R,6S, which is the same as compound 1 based on the NOE correlations of H-1/H-5, H-5/H-6, and H-1/H-6 in compound 2. Thus, 2 was identified as the known compound, rel-(1R,5R,6S)-5-hydroxybicyclo[4,3,0]non-2-ene-2-carboxaldehyde (Figure 1) [10,11].
Relative configurations for 1 and 2, were determined according to their NOESY data as described in the results. Compounds 1 and 2 have the same relative configurations as they showed identical NOESY correlations of H-1/H5, H-1/H-6, and H-5/H-6, which indicate that the three protons of H-1, H-5, and H-6 are in cis configuration with each other. To determine their absolute configurations, Mosher’s esterification experiments were performed for 1 and 2. However, the results showed identical 1H NMR spectra of (R)- and (S)-MTPA esters, indicating racemic mixtures. The optical rotation values of 1 and 2 were [α]22D −1.65 (c 0.1, MeOH) and [α]20D −0.96 (c 0.1, CH2Cl2), respectively, which indicates that they were not perfectly racemic. However, we were unable to find any differences in chemical shifts in the 1H NMR spectra of (R)- and (S)-MTPA esters of compounds 1 and 2. Thus, we think that 1 and 2 are racemic mixtures. All figures, including 1D and 2D NMR spectra of compounds 1 and 2, and the 1H NMR data for MPTA esters of compounds 1 and 2, were provided in the supplementary materials (Figures S1–S24).

2.2. AChE-Inhibitory Activities of 14

In the present study, compounds 14 showed possible inhibitory activity against AChE in molecular docking simulations, and thus, in vitro assays have been performed against AChE and more details are as follows.

2.2.1. In Silico Docking Simulation

Before the in vitro anti-AChE activity test, an in silico docking simulation was performed to predict the specific pharmacological effects of the four compounds (14) against AChE. The binding sites in the enzyme and binding energies of each compound were predicted through a docking simulation utilizing three systems (Autodock vina, Autodock 4, LeDock). Figure 3 shows the binding sites of the AChE receptor and ligands. FP1, the positive control, had two hydrogen bonds and two hydrophobic interactions with AChE (Figure 3a). The binding affinity of the tested compounds was compared to those of the control (FP1) for hydrogen bonding and hydrophobic interaction. Tsaokoic acid (1) and tsaokoin (2) did not have hydrophobic interactions with the enzyme and thus showed lower binding affinities than the control (FP1) (Figure 3b,c). Vanillin (3) possessed one hydrogen bond and one hydrophobic interaction with AChE, showing a lower binding force than the control (Figure 3d). On the other hand, tsaokoarylone (4) showed a stronger binding affinity than the control (FP1) as four hydrophobic interactions and two hydrogen bonds were observed (Figure 3e).
The docking scores of the receptor and compounds are shown in Table 2. Higher absolute values indicate a stronger binding affinity. A control group (FP1) showed −5.6, −5.11, and −2.52 for the Autodock Vina, Autodock 4, and LeDock systems, respectively. Tsaokoic acid (1), tsaokoin (2), and vanillin (3) showed scores to AChE with values of −5.8~−6.8 (Autodock Vina), −5.17~−6.07 (Autodock 4), and −2.7~−3.32 (LeDock), which were higher than those of FP1. On the other hand, tsaokoarylone (4) showed the highest docking scores, −7.2, −8.58, and −4.1, which corresponded to the docking simulation results. All the docking simulations were repeated three times.

2.2.2. In Vitro Assay for AChE-Inhibitory Activity

On the basis of the results from the in silico docking simulation for AChE-inhibitory activity, 14 were tested in vitro screening system at total concentrations of 2, 10, and 50 μM and berberine was used as a positive control (Figure 4 and Table S1). The half-maximal inhibitory concentrations (IC50) of 14 were 32.78, 41.70, 39.25, and 31.13 μM, respectively, as shown in Figure 4. These results can be considered as moderate AChE-inhibitory activity compared to the positive control, berberine (IC50 0.19 μM). Isolates 14 showed consistent activity between in silico and in vitro experiments. Therefore, we can utilize this in silico docking simulation system to find any possible AChE inhibitors before we perform the in vitro or in vivo experiments to save our time and expenses. This is the first report on the AChE-inhibitory activities of compounds 1, 2, and 4. Compound 2, tsaokoin, was reported to have weak antifungal activity in previous studies, but its AChE-inhibitory activity has not been reported [10]. Previous in vitro and in vivo reports indicate that compound 3 has AChE-inhibitory activities [12,13,14]. In this study, in silico docking experiments on AChE for vanillin (3) were performed for the first time as well as for compounds 1, 2, and 4. This study is considered a good example of in silico research that aligns with in vitro results. Their AChE-inhibitory activity indicates that compounds 14 have some possibilities to treat mild Alzheimer’s disease, by increasing the level of ACh.

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotation data were obtained on a JASCO P-2000 polarimeter (Tokyo, Japan). UV spectra were measured on a Hitachi U-3000 UV/Vis spectrophotometer (Tokyo, Japan). IR spectra were recorded on a Thermo Fisher Nicolet iS 10 FT-IR spectrometer (Waltham, MA, USA). NMR spectra were acquired on an Agilent DD2 400 MHz FT-NMR instrument (Agilent Technologies, Santa Clara, CA, USA) using tetramethylsilane as an internal standard and analyzed with MestreNova 9.0.0 software (Mestrelab Research S.L., Santiago de Compostela, Spain). HRESIMS was performed on an Agilent 6230 TOF LC/MS instrument (Agilent Technologies, Santa Clara, CA, USA) equipped at Ewha Drug Development Research Core Center. Adsorption column chromatography was conducted using silica gel (63–200 μm, Merck, Darmstadt, Germany). MPLC was run on a CombiFlash Rf-200 instrument (Teledyne Isco, Lincoln, NE, USA) and RediSep® Silver Silica Gel Disposable Flash Columns 330.0 g and 24.0 g (Teledyne Isco, Lincoln, NE, USA) were used for separations. The Acme 9000 system (Young Lin, Anyang-si, Gyeonggi-do, Republic of Korea) with UV detection was used for analytic HPLC, equipped with an Agilent Prep-C18 Scalar column (4.6 × 250 mm, 5 µm, Santa Clara, CA, USA). Preparative HPLC was carried out on a YMC-Pack Pro C 18 column (20 × 250 mm, 5 µm, Asan-si, Chungcheongnam-do, Republic of Korea) using a Waters system equipped with a Waters 600 pump and a Waters 996 photodiode array detector (Waters, MA, USA). Thin-layer chromatography (TLC) was conducted using Kieselgel 60 F254 aluminum sheets (Merck, Darmstadt, Germany) and RP-18 F254s aluminum sheets (Merck, Darmstadt, Germany). TLC plates were visualized under UV (254 and 365 nm) after being dipped in a 10% (v/v) sulfuric acid solution and heated at 300 °C for 1 min. The solvents used for HPLC experiments were HPLC-grade (Daejung Chemicals & Metals, Siheung-si, Gyeonggi-do, Republic of Korea). Solvents for NMR experiments were purchased from Cambridge Isotope Laboratories (Tewksbury, MA, USA).

3.2. Plant Material

The dried fruits of Amomum tsaoko Crevost et Lemaire (Zingiberaceae) were purchased from Nonglim Saengyak Company (Agricultural and Forestry Herb Market) in Seoul, South Korea in June 2020. A voucher specimen (no. EA389) was deposited at the Natural Product Chemistry Laboratory, College of Pharmacy, Ewha Womans University.

3.3. Extraction and Isolation

The dried fruits of A. tsaoko (10.0 kg) were extracted three times with 32 L of MeOH at room temperature over a period of one week each time. The extract was dried under reduced pressure to obtain 606.0 g of a MeOH concentrate. After dissolving the concentrate in distilled water (1 L), the mixture was sequentially fractionated with n-hexane (10 × 1 L), EtOAc (12 × 1 L), and n-BuOH (10 × 1 L) to afford n-hexane-soluble (112.0 g), EtOAc-soluble (144.0 g), n-BuOH-soluble concentrate (132.0 g), and aqueous residue (216.0 g), respectively. The EtOAc fraction (144.0 g) was applied to a silica gel column chromatography using a gradient solvent system of CH2Cl2-MeOH (100:0 to 0:100, v/v) to obtain nine fractions (F01–F09). Fraction F02 (2.3 g) was subjected to MPLC with a gradient mixture of n-hexane-EtOAc (100:0 to 0:100, v/v) successively to provide 2 (26 mg) with eight subfractions (F02.15.01–F02.15.08). Fraction F03 (8.1 g) was subjected to MPLC with a gradient solvent system (n-hexane-EtOAc, 90:10 to 0:100, v/v) to yield 14 subfractions (F03.01–F03.14). Fraction F03.07 (744 mg) was loaded on successive MPLC separations, and then subfraction F03.07.03.02 was purified using preparative HPLC with MeOH-H2O (60:40, 2 mL/min) to obtain 3 (3 mg; tR 26 min). Fraction F03.08 (1.5 g) was separated by MPLC using n-hexane-acetone (100:0 to 0:100, v/v) to give six subfractions (F03.08.01–F.03.08.06) and fraction F03.08.02 (1.0 g) was separated using n-hexane-acetone (100:0 to 70:30, v/v) to obtain six subfractions (F03.08.02.01–F.03.08.02.06). Fraction F03.08.02.05 (89 mg) was further purified by preparative HPLC eluting with an isocratic mixture of MeOH-H2O (60:40, 2 mL/min) to isolate 1 (30 mg; tR 15 min). Fraction F03.10 (143 mg) was fractionated by MPLC with n-hexane-acetone (100:0 to 70:30 v/v) to afford four subfractions (F03.10.01–F03.10.04). Fraction F03.10.02 (20 mg) was loaded on the HPLC using MeOH-H2O (60:40, 2 mL/min) to purify 4 (5 mg; tR 20 min).
Tsaokoic acid (1): White needles; [α]22D −1.65 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 240 (2.72) nm; IR (KBr) νmax 2954, 2868, 1685, 1638, 1249, 1054 cm−1; 1H NMR (CD3OD, 400 MHz) and 13C NMR (CD3OD, 100 MHz) data, see Table 1; HRESIMS m/z 181.0868 [M − H] (calcd for C10H14O3, 181.0870).
Tsaokoin (2): Colorless oil; [α]20D −0.96 (c 0.1, CH2Cl2); UV (CH2Cl2) λmax (log ε) 230 (2.40) nm; IR (KBr) νmax 3418, 2955, 2869, 2722, 1681, 1635, 1451, 1430, 1378, 1309, 1167, 1115, 1061, 1025, 968, 926, 902, 827, 739, 585 cm−1; 1H NMR (CDCl3, 400 MHz) and 13C NMR (CDCl3, 100 MHz) data, see Table 1; HRESIMS m/z 167.1072 [M + H]+ (calcd for C10H14O2, 167.1067).
Vanillin (3): White powder; 1H NMR and 13C NMR data were comparable to the reference data [15].
Tsaokoarylone (4): Yellowish amorphous solid; 1H NMR and 13C NMR data were comparable to the reference data [16].

3.4. In Silico AChE-Inhibitory Activity

For the docking studies, the crystal structure of AChE was obtained from the RCSC PDB website (PDB ID: 5HFA) (https://www.rcsb.org/, accessed on 20 September 2022). The 3D structures of tsaokoic acid, tsaokoin, and tsaokoarylone were built by ACD/ChemSketch freeware (ACD/Labs, Toronto, ON, Canada) (https://www.acdlabs.com/resources/free-chemistry-software-apps/chemsketch-freeware/, accessed on 20 September 2022), while the 3D structure of vanillin was obtained from the Pubchem website (https://pubchem.ncbi.nlm.nih.gov/, accessed on 20 September 2022). Three programs were used for docking simulation: Autodock Vina 1.1.2 (Scripps Research, San Diego, CA, USA) (https://vina.scripps.edu/, accessed on 20 September 2022), Autodock4.2.6 (Scripps Research, San Diego, CA, USA) (https://autodock.scripps.edu/, accessed on 20 September 2022), and LeDock (LEPHAR, http://www.lephar.com/software.htm, accessed on 20 September 2022). Docking preparation of four compounds was conducted by UCSF Chimera program (University of California, San Francisco, CA, USA) (https://www.rbvi.ucsf.edu/chimera/, accessed on September 2022). A pharmacophore analysis between AChE and the compounds was conducted by LigandScout 4.0 (inte:ligand, Maria Enzersdorf, Niedaestareich, Austria) (http://www.inteligand.com/ligandscout/, accessed on 20 September 2022).

3.5. In Vitro AChE-Inhibitory Assay

The inhibitory activities of the compounds on AChE were measured using the spectrophotometric method developed by Ellman et al. 1961 [17]. The reaction mixtures contained 140 µL of sodium phosphate buffer (pH 8.0), 20 µL of tested sample solution, and 20 µL of AChE solution, which were mixed and incubated for 15 min at room temperature. All tested compounds and positive control (berberine) were dissolved in 10% DMSO Reactions were initiated with the addition of 10 µL of dithiobisnitrobenzoic acid (DTNB) and 10 µL of ACh. The hydrolysis of ACh was monitored by tracking the formation of 5-thio-2-nitrobenzoate anion at 412 nm for 15 min, resulting from the reaction of DTNB with the thiocholine released by the enzyme. Each reaction was performed in triplicate and the results were measured in 96-well microplates using a microplate spectrophotometer (Tecan, Sunrise, Austria). Percent inhibition was calculated using the formula (1 − S/E) × 100, where E and S are enzyme activities with and without the test sample, respectively. The inhibitory activity of each compound against AChE was expressed as an IC50 (the µM concentration required to inhibit substrate hydrolysis by 50%), as calculated using log-dose inhibition curves.

4. Conclusions

In this study, tsaokoic acid (1), tsaokoin (2), vanillin (3), and tsaokoarylone (4) were isolated from the EtOAc fraction of the A. tsao-ko fruits. Compound 1 was elucidated as a new compound, tsaokoic acid, using various spectroscopic data including 1D and 2D NMR techniques such as COSY, NOESY, HSQC, and HMBC NMR experiments. Relative configurations for 1 and 2 were determined according to their NOESY data as described in the results. Compounds 14 exhibited moderate AChE-inhibitory activities at IC50 values of 32.78, 41.70, 39.25, and 31.13 μM, respectively, which are consistent with the results of in silico docking simulations. From these results, we can conclude that in silico docking simulation system for AChE-inhibitory activiy could be a guide for in vitro system. Compounds 14 isolated from the fruits of A. tsao-ko, have some possibilities to enhance cognition in humans, treating mild Alzheimer’s disease.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28062602/s1. Figures S1–S7 with 1D/2D NMR spectroscopic data of compound 1; Figures S8–S10 with UV, IR, HRESIMS data of compound 1; Figures S11–S17 with 1D/2D NMR spectroscopic data of compound 2; Figures S18–S20 with UV, IR, HRESIMS data of compound 2; Figures S21–S24 with 1H-NMR data of MTPA esters of 1 and 2; Table S1 with AChE-inhibitory activity of the isolates 14.

Author Contributions

H.K. (Hyunyoung Kim) and H.L. contributed equally to this work. Conceptualization, H.Y.C. and E.K.S.; Formal analysis, H.K. (Hyunyoung Kim), H.L., H.J.J. and S.G.N.; Investigation, H.K. (Hyunyoung Kim), H.L., H.J.J., S.G.N., H.K. (Hyunkyung Kwak) and Y.L.; Resources, S.-J.N. and H.Y.C.; Validation, S.K.; Writing—original draft, H.L. and I.Y.; Writing—review & editing, I.Y. and E.K.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MIST) (No. 2021R1A2C1003350). This research was supported by Korea Basic Science Institute (National research Facilities and Equipment Center) grant funded by the Ministry of Education (2021R1A6C101A442).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Song, Q.S.; Teng, R.W.; Liu, X.K.; Yang, C.R. Tsaokoin, a new bicyclic nonane from Amomum tsao-ko. Chin. Chem. Lett. 2001, 12, 227–230. [Google Scholar]
  2. Cai, R.; Yue, X.; Wang, Y.; Yang, Y.; Sun, D.; Li, H.; Chen, L. Chemistry and bioactivity of plants from the genus Amomum. J. Ethnopharmacol. 2021, 281, 114563. [Google Scholar] [CrossRef] [PubMed]
  3. Yang, S.; Xue, Y.; Chen, D.; Wang, Z. Amomum tsao-ko Crevost & Lemarié: A comprehensive review on traditional uses, botany, phytochemistry, and pharmacology. Phytochem. Rev. 2022, 21, 1487–1521. [Google Scholar] [PubMed]
  4. Yang, X.; Küenzi, P.; Plitzko, I.; Potterat, O.; Hamburger, M. Bicyclononane aldehydes and antiproliferative constituents from Amomum tsao-ko. Planta Med. 2009, 75, 543–546. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Zhang, T.-T.; Lu, C.-L.; Jiang, J.-G. Bioactivity evaluation of ingredients identified from the fruits of Amomum tsaoko Crevost et Lemaire, a Chinese spice. Food Funct. 2014, 5, 1747–1754. [Google Scholar] [CrossRef] [PubMed]
  6. Kim, J.G.; Jang, H.; Le, T.P.L.; Hong, H.R.; Lee, M.K.; Hong, J.T.; Lee, D.; Hwang, B.Y. Pyranoflavanones and pyranochalcones from the fruits of Amomum tsao-ko. J. Nat. Prod. 2019, 82, 1886–1892. [Google Scholar] [CrossRef] [PubMed]
  7. He, X.-F.; Zhang, X.-K.; Geng, C.-A.; Hu, J.; Zhang, X.-M.; Guo, Y.-Q.; Chen, J.-J. Tsaokopyranols A–M, 2, 6-epoxydiarylheptanoids from Amomum tsao-ko and their α-glucosidase inhibitory activity. Bioorganic Chem. 2020, 96, 103638. [Google Scholar] [CrossRef] [PubMed]
  8. Marucci, G.; Buccioni, M.; Ben, D.D.; Lambertucci, C.; Volpini, R.; Amenta, F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology 2021, 190, 108352. [Google Scholar] [CrossRef] [PubMed]
  9. Breijyeh, Z.; Karaman, R. Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules 2020, 25, 5789. [Google Scholar] [CrossRef] [PubMed]
  10. Moon, S.-S.; Lee, J.-Y.; Cho, S.-C. Isotsaokoin, an antifungal agent from Amomum tsao-ko. J. Nat. Prod. 2004, 67, 889–891. [Google Scholar] [CrossRef] [PubMed]
  11. Kang, U.; Han, A.-R.; So, Y.; Jin, C.H.; Ryu, S.M.; Lee, D.; Seo, E.K. Furanocoumarins from the roots of angelica dahurica with inhibitory activity against intracellular reactive oxygen species accumulation. J. Nat. Prod. 2019, 82, 2601–2607. [Google Scholar] [CrossRef] [PubMed]
  12. Kundu, A.; Mitra, A. Flavoring extracts of Hemidesmus indicus roots and Vanilla planifolia pods exhibit in vitro acetylcholinesterase inhibitory activities. Plant Food Hum. Nutr. 2013, 68, 247–253. [Google Scholar] [CrossRef] [PubMed]
  13. Abuhamdah, S.; Thalji, D.; Abuirmeileh, N.; Bahnassi, A.; Salahat, I.; Abuirmeileh, A. Behavioral and neurochemical alterations induced by vanillin in a mouse model of Alzheimer’s disease. Int. J. Pharmacol. 2017, 13, 573–582. [Google Scholar] [CrossRef] [Green Version]
  14. Iannuzzi, C.; Liccardo, M.; Sirangelo, I. Overview of the Role of Vanillin in Neurodegenerative Diseases and Neuropathophysiological Conditions. Int. J. Mol. Sci. 2023, 24, 1817. [Google Scholar] [CrossRef] [PubMed]
  15. Mahnashi, M.H.; Alyami, B.A.; Alqahtani, Y.S.; Alqarni, A.O.; Jan, M.S.; Hussain, F.; Zafar, R.; Rashid, U.; Abbas, M.; Tariq, M.; et al. Antioxidant molecules isolated from edible Prostrate Knotweed: Rational derivatization to produce more potent molecules. Oxidative Med. Cell. Longev. 2022, 2022, 1–15. [Google Scholar] [CrossRef] [PubMed]
  16. Moon, S.-S.; Cho, S.-C.; Lee, J.-Y. Tsaokoarylone, a cytotoxic diarylheptanoid from Amomum tsao-ko fruits. Bull. Korean Chem. Soc. 2005, 26, 447–450. [Google Scholar] [CrossRef]
  17. Ellman, G.L.; Courtney, K.D.; Andres, A., Jr.; Featherstone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88–95. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of isolates 14 from A. tsao-ko.
Figure 1. Chemical structures of isolates 14 from A. tsao-ko.
Molecules 28 02602 g001
Figure 2. Key COSY, NOESY and HMBC correlations of 1.
Figure 2. Key COSY, NOESY and HMBC correlations of 1.
Molecules 28 02602 g002
Figure 3. The pharmacophores of the tested compounds indicate the interactions between the receptor (AChE) and ligands (14 and FP1). The green and red arrows indicate the hydrogen bond donor and acceptor, respectively. The yellow color indicates a hydrophobic interaction or van der Waals Force. (a) FP1, a positive control, (b) 1, (c) 2, (d) 3, and (e) 4.
Figure 3. The pharmacophores of the tested compounds indicate the interactions between the receptor (AChE) and ligands (14 and FP1). The green and red arrows indicate the hydrogen bond donor and acceptor, respectively. The yellow color indicates a hydrophobic interaction or van der Waals Force. (a) FP1, a positive control, (b) 1, (c) 2, (d) 3, and (e) 4.
Molecules 28 02602 g003
Figure 4. AChE-inhibitory activity (%) of the four compounds (14) at three concentrations by five-fold dilution. * Concentrations of the control (berberine) were 0.04, 0.2, and 1.0 µM, respectively.
Figure 4. AChE-inhibitory activity (%) of the four compounds (14) at three concentrations by five-fold dilution. * Concentrations of the control (berberine) were 0.04, 0.2, and 1.0 µM, respectively.
Molecules 28 02602 g004
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data for 1 and 2.
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data for 1 and 2.
Position1 a2 b
δCTypeδH (J in Hz)δCTypeδH (J in Hz)
140.9CH3.01 ddt (9.8, 3.3, 1.6)37.3CH2.98 m
2135.9C 144.9C
3136.5CH6.78 dq (6.0, 1.5)146.5CH6.64 ddd (5.6, 3.2, 1.3)
430.8CH22.32 ddt (17.8, 6.0, 1.5)31.2CH22.53 dtt (18.4, 5.2, 1.5)
2.22 ddt (18.0, 9.4, 2.9) 2.40 td (8.6, 2.9)
568.9CH3.94 dt (9.6, 4.8)68.4CH4.05 dt (8.8, 4.8)
644.6CH2.41 dddd (12.6, 8.0, 4.0, 1.4)42.8CH2.44 dt (8.8, 2.8)
726.0CH21.72 dddd (16.4, 8.4, 5.2, 4.1)25.0CH21.78 td (8.8, 5.2)
1.55 m 1.63 m
825.4CH21.55 m24.7CH21.56 ddd (15.6, 7.2, 1.9)
934.2CH22.03 dq (5.6, 2.4)32.3CH22.12 ddd (20.8, 7.6, 5.1)
1.45 m 1.41 tdd (13.2, 5.6, 1.7)
10170.7COOH 193.8CHO9.42s
a Data were measured in CD3OD. b Data were measured in CDCl3.
Table 2. In silico docking scores of the control and the compounds 14 against AChE.
Table 2. In silico docking scores of the control and the compounds 14 against AChE.
CompoundAutodock Vina aAutodock4 aLeDock aNo. of H-BondH-Bond
Interacting Residues
Hydrophobic
Interacting Residues
FP1 b−5.6−5.11−2.522HIS447B, TYR449BILE451B, TRP86B
1−6.8−5.24−3.321TYR124B
2−6.3−6.07−2.932HIS447B, SER125B
3−5.8−5.17−2.71TYR341BTYR124B
4−7.2−8.58−4.12TYR72B, TYR124BPHE338B, TRP86B, TYR337B
a Unit: Kcal/mol, b Control.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kim, H.; Lee, H.; Jung, H.J.; Noh, S.G.; Youn, I.; Kwak, H.; Lee, Y.; Nam, S.-J.; Kang, S.; Chung, H.Y.; et al. Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity. Molecules 2023, 28, 2602. https://doi.org/10.3390/molecules28062602

AMA Style

Kim H, Lee H, Jung HJ, Noh SG, Youn I, Kwak H, Lee Y, Nam S-J, Kang S, Chung HY, et al. Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity. Molecules. 2023; 28(6):2602. https://doi.org/10.3390/molecules28062602

Chicago/Turabian Style

Kim, Hyunyoung, Hwaryeong Lee, Hee Jin Jung, Sang Gyun Noh, Isoo Youn, Hyunkyung Kwak, Yeju Lee, Sang-Jip Nam, Soosung Kang, Hae Young Chung, and et al. 2023. "Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity" Molecules 28, no. 6: 2602. https://doi.org/10.3390/molecules28062602

APA Style

Kim, H., Lee, H., Jung, H. J., Noh, S. G., Youn, I., Kwak, H., Lee, Y., Nam, S. -J., Kang, S., Chung, H. Y., & Seo, E. K. (2023). Tsaokoic Acid: A New Bicyclic Nonene from the Fruits of Amomum tsao-ko with Acetylcholinesterase Inhibitory Activity. Molecules, 28(6), 2602. https://doi.org/10.3390/molecules28062602

Article Metrics

Back to TopTop